Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 208

1.

Evaluation of accuracy of hepatitis B virus antigen and antibody detection and relationship between epidemiological factors using dried blood spot.

Cruz HM, de Paula VS, Cruz JCM, do Ó KMR, Milagres FAP, Bastos FI, Mota JCD, Cruz MS, Andrade TM, Pollo-Flores P, Leal E, Motta-Castro ARC, Ivantes CAP, Bezerra CS, Barbosa JR, da Cruz JNM, Lewis-Ximenez LL, Villar LM.

J Virol Methods. 2019 Dec 16;277:113798. doi: 10.1016/j.jviromet.2019.113798. [Epub ahead of print]

PMID:
31837375
2.

Analysis of miRNA signatures in CSF identifies upregulation of miR-21 and miR-146a/b in patients with multiple sclerosis and active lesions.

Muñoz-San Martín M, Reverter G, Robles-Cedeño R, Buxò M, Ortega FJ, Gómez I, Tomàs-Roig J, Celarain N, Villar LM, Perkal H, Fernández-Real JM, Quintana E, Ramió-Torrentà L.

J Neuroinflammation. 2019 Nov 14;16(1):220. doi: 10.1186/s12974-019-1590-5.

3.

Adaptive Features of Natural Killer Cells in Multiple Sclerosis.

Moreira A, Alari-Pahissa E, Munteis E, Vera A, Zabalza A, Llop M, Villarrubia N, Costa-García M, Álvarez-Lafuente R, Villar LM, López-Botet M, Martínez-Rodríguez JE.

Front Immunol. 2019 Oct 15;10:2403. doi: 10.3389/fimmu.2019.02403. eCollection 2019.

4.

Genetic Diversity of the Hepatitis B Virus Subgenotypes in Brazil.

Lago BV, do Espirito-Santo MP, Costa VD, Marques VA, Villar LM, Lewis-Ximenez LL, Lampe E, Mello FCA.

Viruses. 2019 Sep 15;11(9). pii: E860. doi: 10.3390/v11090860.

5.

Usefulness of automated assays for detecting hepatitis B and C markers in dried blood spot samples.

Villar LM, Cruz HM, Deodato RM, Miguel JC, da Silva EF, Flores GL, Lewis-Ximenez LL.

BMC Res Notes. 2019 Aug 20;12(1):523. doi: 10.1186/s13104-019-4547-y.

6.

Phenotypic and Ig Repertoire Analyses Indicate a Common Origin of IgD-CD27- Double Negative B Cells in Healthy Individuals and Multiple Sclerosis Patients.

Fraussen J, Marquez S, Takata K, Beckers L, Montes Diaz G, Zografou C, Van Wijmeersch B, Villar LM, O'Connor KC, Kleinstein SH, Somers V.

J Immunol. 2019 Sep 15;203(6):1650-1664. doi: 10.4049/jimmunol.1801236. Epub 2019 Aug 7.

PMID:
31391234
7.

Evaluation of HBV-Like Circulation in Wild and Farm Animals from Brazil and Uruguay.

Vieira YR, Portilho MM, Oliveira FF, Guterres A, Dos Santos DRL, Villar LM, Mirazo S, Arbiza J, Dimache LAG, Almeida FQ, Brandão ML, Cordeiro JLP, Rocha FL, Azevedo FC, Lemos FG, Campos JBV, Macedo GC, Herrera HM, Péres IAS, Zimmermann NP, Piovezan U, Pellegrin AO, de Paula VS, Pinto MA.

Int J Environ Res Public Health. 2019 Jul 26;16(15). pii: E2679. doi: 10.3390/ijerph16152679.

8.

Utility of oral fluid samples for hepatitis B antibody detection in real life conditions.

Cruz HM, de Paula VS, da Silva EF, do Ó KMR, Milagres FAP, Cruz MS, Bastos FI, da Mota JC, Pollo-Flores P, Leal E, Motta-Castro ARC, Lewis-Ximenez LL, Lampe E, Villar LM.

BMC Infect Dis. 2019 Jul 17;19(1):632. doi: 10.1186/s12879-019-4183-0.

9.

Manipulation of Gut Microbiota Influences Immune Responses, Axon Preservation, and Motor Disability in a Model of Progressive Multiple Sclerosis.

Mestre L, Carrillo-Salinas FJ, Mecha M, Feliú A, Espejo C, Álvarez-Cermeño JC, Villar LM, Guaza C.

Front Immunol. 2019 Jun 14;10:1374. doi: 10.3389/fimmu.2019.01374. eCollection 2019.

10.

A pharmacogenetic study implicates NINJ2 in the response to Interferon-β in multiple sclerosis.

Peroni S, Sorosina M, Malhotra S, Clarelli F, Osiceanu AM, Ferrè L, Roostaei T, Rio J, Midaglia L, Villar LM, Álvarez-Cermeño JC, Guaschino C, Radaelli M, Citterio L, Lechner-Scott J, Spataro N, Navarro A, Martinelli V, Montalban X, Weiner HL, de Jager P, Comi G, Esposito F, Comabella M, Martinelli-Boneschi F.

Mult Scler. 2019 Jun 21:1352458519851428. doi: 10.1177/1352458519851428. [Epub ahead of print]

PMID:
31221001
11.

Diagnostic Value of Cerebrospinal Fluid Neurofilament Light Protein in Neurology: A Systematic Review and Meta-analysis.

Bridel C, van Wieringen WN, Zetterberg H, Tijms BM, Teunissen CE; and the NFL Group, Alvarez-Cermeño JC, Andreasson U, Axelsson M, Bäckström DC, Bartos A, Bjerke M, Blennow K, Boxer A, Brundin L, Burman J, Christensen T, Fialová L, Forsgren L, Frederiksen JL, Gisslén M, Gray E, Gunnarsson M, Hall S, Hansson O, Herbert MK, Jakobsson J, Jessen-Krut J, Janelidze S, Johannsson G, Jonsson M, Kappos L, Khademi M, Khalil M, Kuhle J, Landén M, Leinonen V, Logroscino G, Lu CH, Lycke J, Magdalinou NK, Malaspina A, Mattsson N, Meeter LH, Mehta SR, Modvig S, Olsson T, Paterson RW, Pérez-Santiago J, Piehl F, Pijnenburg YAL, Pyykkö OT, Ragnarsson O, Rojas JC, Romme Christensen J, Sandberg L, Scherling CS, Schott JM, Sellebjerg FT, Simone IL, Skillbäck T, Stilund M, Sundström P, Svenningsson A, Tortelli R, Tortorella C, Trentini A, Troiano M, Turner MR, van Swieten JC, Vågberg M, Verbeek MM, Villar LM, Visser PJ, Wallin A, Weiss A, Wikkelsø C, Wild EJ.

JAMA Neurol. 2019 Jun 17. doi: 10.1001/jamaneurol.2019.1534. [Epub ahead of print]

PMID:
31206160
12.

Kappa free light chains is a valid tool in the diagnostics of MS: A large multicenter study.

Leurs CE, Twaalfhoven H, Lissenberg-Witte BI, van Pesch V, Dujmovic I, Drulovic J, Castellazzi M, Bellini T, Pugliatti M, Kuhle J, Villar LM, Alvarez-Cermeño JC, Alvarez-Lafuente R, Hegen H, Deisenhammer F, Walchhofer LM, Thouvenot E, Comabella M, Montalban X, Vécsei L, Rajda C, Galimberti D, Scarpini E, Altintas A, Rejdak K, Frederiksen JL, Pihl-Jensen G, Jensen P, Khalil M, Voortman MM, Fazekas F, Saiz A, La Puma D, Vercammen M, Vanopdenbosch L, Uitdehaag B, Killestein J, Bridel C, Teunissen C.

Mult Scler. 2019 May 8:1352458519845844. doi: 10.1177/1352458519845844. [Epub ahead of print]

PMID:
31066634
13.

Applicability of Oral Fluid and Dried Blood Spot for Hepatitis B Virus Diagnosis.

Villar LM, Bezerra CS, Cruz HM, Portilho MM, Flores GL.

Can J Gastroenterol Hepatol. 2019 Apr 1;2019:5672795. doi: 10.1155/2019/5672795. eCollection 2019. Review.

14.

Neurofilament light chain levels in pregnant multiple sclerosis patients: a prospective cohort study.

Cuello JP, Martínez Ginés ML, Kuhle J, García Domínguez JM, Lozano Ros A, Romero Delgado F, Higueras Y, Meldaña Rivera A, Goicochea Briceño H, García-Tizon Larroca S, De León-Luis J, Michalak Z, Barro C, Álvarez Lafuente R, Medina Heras S, Fernández Velasco JI, Tejeda-Velarde A, Domínguez-Mozo MI, Muriel A, de Andrés C, Villar LM.

Eur J Neurol. 2019 Sep;26(9):1200-1204. doi: 10.1111/ene.13965. Epub 2019 May 9.

PMID:
30977955
15.

Hepatitis A Strain Linked to the European Outbreaks During Gay Events between 2016 and 2017, Identified in a Brazilian Homosexual Couple in 2017.

Mello VM, Lago BV, Sousa PSF, Mello FCA, Souza CB, Pinto LCM, Ginuino CF, Fernandes CAS, Aguiar SF, Villar LM, Lampe E, Melgaço JG, Lewis-Ximenez LL.

Viruses. 2019 Mar 20;11(3). pii: E281. doi: 10.3390/v11030281.

16.

Teriflunomide induces a tolerogenic bias in blood immune cells of MS patients.

Medina S, Sainz de la Maza S, Villarrubia N, Álvarez-Lafuente R, Costa-Frossard L, Arroyo R, Monreal E, Tejeda-Velarde A, Rodríguez-Martín E, Roldán E, Álvarez-Cermeño JC, Villar LM.

Ann Clin Transl Neurol. 2019 Jan 15;6(2):355-363. doi: 10.1002/acn3.711. eCollection 2019 Feb.

17.

Prevalence of hepatitis B and hepatitis C among diabetes mellitus type 2 individuals.

Villar LM, Geloneze B, Vasques ACJ, Pires MLE, Miguel JC, da Silva EF, Marques VA, Scalioni LP, Lampe E.

PLoS One. 2019 Feb 28;14(2):e0211193. doi: 10.1371/journal.pone.0211193. eCollection 2019.

18.

Factors associated with dimethyl fumarate-induced lymphopenia.

Sainz de la Maza S, Medina S, Villarrubia N, Costa-Frossard L, Monreal E, Tejeda-Velarde A, Rodríguez-Martín E, Roldán E, Álvarez-Cermeño JC, Villar LM.

J Neurol Sci. 2019 Mar 15;398:4-8. doi: 10.1016/j.jns.2019.01.007. Epub 2019 Jan 8.

PMID:
30658226
19.

Cross-sectional study to determine viral hepatitis knowledge in different urban populations in Brazil.

Cruz HM, Barbosa JR, Baima Colares JK, de Moraes Neto AHA, Alencar MFL, Bastos FI, da Mota JC, Carvalho-Costa FA, Ivantes CAP, Lewis-Ximenez LL, Villar LM.

World J Hepatol. 2018 Nov 27;10(11):867-876. doi: 10.4254/wjh.v10.i11.867.

20.

Multi-centre validation of a flow cytometry method to identify optimal responders to interferon-beta in multiple sclerosis.

Villarrubia N, Rodríguez-Martín E, Alari-Pahissa E, Aragón L, Castillo-Triviño T, Eixarch H, Ferrer JM, Martínez-Rodríguez JE, Massot M, Pinto-Medel MJ, Prada Á, Rodríguez-Acevedo B, Urbaneja P, Gascón-Gimenez F, Herrera G, Hernández-Clares R, Salgado MG, Oterino A, San Segundo D, Cuello JP, Gil-Herrera J, Cámara C, Gómez-Gutiérrez M, Martínez-Hernández E, Meca-Lallana V, Moga E, Muñoz-Calleja C, Querol L, Presas-Rodríguez S, Teniente-Serra A, Vlagea A, Muriel A, Roldán E, Villar LM.

Clin Chim Acta. 2019 Jan;488:135-142. doi: 10.1016/j.cca.2018.11.008. Epub 2018 Nov 5.

PMID:
30408481
21.

Circulating EZH2-positive T cells are decreased in multiple sclerosis patients.

Malhotra S, Villar LM, Costa C, Midaglia L, Cubedo M, Medina S, Fissolo N, Río J, Castilló J, Álvarez-Cermeño JC, Sánchez A, Montalban X, Comabella M.

J Neuroinflammation. 2018 Oct 26;15(1):296. doi: 10.1186/s12974-018-1336-9.

22.

Quantification of the Light Subunit of Neurofilament Protein in Cerebrospinal Fluid of Huntington's Disease Patients.

Szejko N, Picón C, García-Caldentey J, de Yebenes JG, Alvarez-Cermeño JC, Villar LM, López-Sendón Moreno JL.

PLoS Curr. 2018 Aug 31;10. pii: ecurrents.hd.280c8f9f7d9fa4f7f0c883d9f8e807da. doi: 10.1371/currents.hd.280c8f9f7d9fa4f7f0c883d9f8e807da.

23.

Exome sequencing study in patients with multiple sclerosis reveals variants associated with disease course.

Gil-Varea E, Urcelay E, Vilariño-Güell C, Costa C, Midaglia L, Matesanz F, Rodríguez-Antigüedad A, Oksenberg J, Espino-Paisan L, Dessa Sadovnick A, Saiz A, Villar LM, García-Merino JA, Ramió-Torrentà L, Triviño JC, Quintana E, Robles R, Sánchez-López A, Arroyo R, Alvarez-Cermeño JC, Vidal-Jordana A, Malhotra S, Fissolo N, Montalban X, Comabella M.

J Neuroinflammation. 2018 Sep 14;15(1):265. doi: 10.1186/s12974-018-1307-1.

24.

gMS-Classifier1 does not predict disability progression in multiple sclerosis.

van Rossum JA, Killestein J, Villar LM, Riskind PN, Freedman MS, Teunissen C.

Mult Scler. 2019 Jun;25(7):1010-1011. doi: 10.1177/1352458518798048. Epub 2018 Aug 31. No abstract available.

25.

Determination of hepatitis B, C and D prevalence among urban and Amerindian populations from the Eastern Brazilian Amazon: a cross sectional study.

Villar LM, Milagres FAP, Lampe E, Cruz HM, Scalioni LP, Magalhães MAFM, Romão AR, Gracie R, de Paula VS.

BMC Infect Dis. 2018 Aug 20;18(1):411. doi: 10.1186/s12879-018-3279-2.

26.

Assessing hepatitis B immunity using dried blood spot samples from HIV+ individuals.

Flores GL, Cruz HM, Miguel JC, Potsch DV, Pilotto JH, Lewis-Ximenez LL, Lampe E, Villar LM.

J Med Virol. 2018 Dec;90(12):1863-1867. doi: 10.1002/jmv.25275. Epub 2018 Sep 3.

PMID:
30085359
27.

Cognitive impairment in early stages of multiple sclerosis is associated with high cerebrospinal fluid levels of chitinase 3-like 1 and neurofilament light chain.

Quintana E, Coll C, Salavedra-Pont J, Muñoz-San Martín M, Robles-Cedeño R, Tomàs-Roig J, Buxó M, Matute-Blanch C, Villar LM, Montalban X, Comabella M, Perkal H, Gich J, Ramió-Torrentà L.

Eur J Neurol. 2018 Sep;25(9):1189-1191. doi: 10.1111/ene.13687. Epub 2018 Jun 22.

PMID:
29797629
28.

Comparison of the performance of enzyme immunoassays for hepatitis B and C detection in dried blood spot.

Cruz HM, Miguel Cruz JC, Da Silva EF, Portilho MM, Marques VA, Lewis-Ximenez LL, Lampe E, Villar LM.

J Immunoassay Immunochem. 2018;39(2):228-233. doi: 10.1080/15321819.2018.1470095. Epub 2018 May 7.

PMID:
29733758
29.

Performance of point of care assays for hepatitis B and C viruses in chronic kidney disease patients.

Barbosa JR, Cortes VF, Portilho MM, Miguel JC, Marques VA, Bezerra CS, de Souza NV, Lima DM, Colares JKB, Lewis-Ximenez LL, Lampe E, Villar LM.

J Clin Pathol. 2018 Oct;71(10):879-884. doi: 10.1136/jclinpath-2018-205024. Epub 2018 May 5.

PMID:
29730611
30.

Hepatitis D infection in Brazil: Prevalence and geographical distribution of anti-Delta antibody.

Lago BV, Mello FCA, Barros TM, Mello VM, Villar LM, Lewis-Ximenez LL, Pardini MIMC, Lampe E; Brazilian Hepatitis B Research Group.

J Med Virol. 2018 Aug;90(8):1358-1363. doi: 10.1002/jmv.25196. Epub 2018 May 1.

PMID:
29663457
31.

Low cytomegalovirus seroprevalence in early multiple sclerosis: a case for the 'hygiene hypothesis'?

Alari-Pahissa E, Moreira A, Zabalza A, Alvarez-Lafuente R, Munteis E, Vera A, Arroyo R, Alvarez-Cermeño JC, Villar LM, López-Botet M, Martínez-Rodríguez JE.

Eur J Neurol. 2018 Jul;25(7):925-933. doi: 10.1111/ene.13622. Epub 2018 Apr 15.

PMID:
29528545
32.

Differential blood cellular profile in patients with moderate-to-severe psoriasis treated with classical systemic therapies: a step forward in personalized medicine.

Hernández-Breijo B, Jurado T, Rodríguez-Martín E, Martínez-Feito A, Plasencia-Rodríguez C, Balsa A, Alonso-Pacheco ML, Villar LM, Herranz-Pinto P, Pascual-Salcedo D.

Br J Dermatol. 2018 Sep;179(3):765-766. doi: 10.1111/bjd.16537. Epub 2018 Jun 21. No abstract available.

PMID:
29526036
33.

Usefulness of in-house real time PCR for HBV DNA quantification in serum and oral fluid samples.

Portilho MM, Mendonça ACDF, Bezerra CS, do Espirito-Santo MP, de Paula VS, Nabuco LC, Villela-Nogueira CA, Lewis-Ximenez LL, Lampe E, Villar LM.

J Virol Methods. 2018 Jun;256:100-106. doi: 10.1016/j.jviromet.2018.03.001. Epub 2018 Mar 4.

PMID:
29514044
34.

Impact of vitamin D receptor and binding protein gene polymorphisms in clinical and laboratory data of HCV patients: Cross sectional study.

Scalioni LP, Santos BRD, Spritzer PM, Villela-Nogueira CA, Laura Lewis-Ximenez L, Pollo-Flores P, Bordalo Cathalá Esberard E, Brandão-Mello CE, Lampe E, Villar LM.

Medicine (Baltimore). 2018 Feb;97(8):e9881. doi: 10.1097/MD.0000000000009881.

35.

Neurofilament light chain and oligoclonal bands are prognostic biomarkers in radiologically isolated syndrome.

Matute-Blanch C, Villar LM, Álvarez-Cermeño JC, Rejdak K, Evdoshenko E, Makshakov G, Nazarov V, Lapin S, Midaglia L, Vidal-Jordana A, Drulovic J, García-Merino A, Sánchez-López AJ, Havrdova E, Saiz A, Llufriu S, Alvarez-Lafuente R, Schroeder I, Zettl UK, Galimberti D, Ramió-Torrentà L, Robles R, Quintana E, Hegen H, Deisenhammer F, Río J, Tintoré M, Sánchez A, Montalban X, Comabella M.

Brain. 2018 Apr 1;141(4):1085-1093. doi: 10.1093/brain/awy021.

PMID:
29452342
36.

Epidemiological investigation and analysis of the NS5B gene and protein variability of non-primate hepacivirus in several horse cohorts in Rio de Janeiro state, Brazil.

Figueiredo AS, Lampe E, de Albuquerque PPLF, Chalhoub FLL, de Filippis AMB, Villar LM, Cruz OG, Pinto MA, de Oliveira JM.

Infect Genet Evol. 2018 Apr;59:38-47. doi: 10.1016/j.meegid.2018.01.017. Epub 2018 Feb 4.

PMID:
29413884
37.

High prevalence of insulin resistance among Brazilian chronic hepatitis C patients.

Villar LM, Caldas GC, Scalioni LP, Miguel JC, Silva EFD, Marques VA, Villela-Nogueira CA, Lewis-Ximenez LL, Lampe E.

Arch Endocrinol Metab. 2017 Dec;61(6):628-632. doi: 10.1590/2359-3997000000315.

38.

A Cross-Sectional Study of Viral Hepatitis Perception among Residents from Southeast and North Regions of Brazil.

Cruz HM, de Paula VS, Villar LM.

Int J Environ Res Public Health. 2018 Jan 24;15(2). pii: E189. doi: 10.3390/ijerph15020189.

39.

Intrathecal oligoclonal bands synthesis in multiple sclerosis: is it always a prognostic factor?

Frau J, Villar LM, Sardu C, Secci MA, Schirru L, Ferraro D, Coghe G, Lorefice L, Fenu G, Bedin R, Sola P, Marrosu MG, Cocco E.

J Neurol. 2018 Feb;265(2):424-430. doi: 10.1007/s00415-017-8716-4. Epub 2017 Dec 22.

PMID:
29273846
40.

Clinical usefulness of prognostic biomarkers in optic neuritis.

Tejeda-Velarde A, Costa-Frossard L, Sainz de la Maza S, Carrasco Á, Espiño M, Picón C, Toboso I, Walo PE, Lourido D, Muriel A, Álvarez-Cermeño JC, Villar LM.

Eur J Neurol. 2018 Apr;25(4):614-618. doi: 10.1111/ene.13553. Epub 2018 Feb 6. Erratum in: Eur J Neurol. 2018 Oct;25(10):1303.

PMID:
29272057
41.

Detection of occult hepatitis B in serum and oral fluid samples.

Portilho MM, Nabuco LC, Villela-Nogueira CA, Brandão-Mello CE, Pilotto JH, Flores GL, Lewis-Ximenez LL, Lampe E, Villar LM.

Mem Inst Oswaldo Cruz. 2018 Jan;113(1):62-65. doi: 10.1590/0074-02760170071.

42.

Correction to: Blood lymphocyte subsets identify optimal responders to IFN-beta in MS.

Alenda R, Costa-Frossard L, Alvarez-Lafuente R, Espejo C, Rodríguez-Martín E, Sainz de la Maza S, Villarrubia N, Río J, Domínguez-Mozo MI, Montalban X, Álvarez-Cermeño JC, Villar LM.

J Neurol. 2018 Jan;265(1):32. doi: 10.1007/s00415-017-8679-5.

PMID:
29177546
43.

NLRP3 polymorphisms and response to interferon-beta in multiple sclerosis patients.

Malhotra S, Sorosina M, Río J, Peroni S, Midaglia L, Villar LM, Álvarez-Cermeño JC, Schroeder I, Esposito F, Clarelli F, Zettl UK, Lechner-Scott J, Spataro N, Navarro A, Comi G, Montalban X, Martinelli-Boneschi F, Comabella M.

Mult Scler. 2018 Oct;24(11):1507-1510. doi: 10.1177/1352458517739137. Epub 2017 Nov 9.

44.

Blood lymphocyte subsets identify optimal responders to IFN-beta in MS.

Alenda R, Costa-Frossard L, Alvarez-Lafuente R, Espejo C, Rodríguez-Martín E, de la Maza SS, Villarrubia N, Río J, Domínguez-Mozo MI, Montalban X, Álvarez-Cermeño JC, Villar LM.

J Neurol. 2018 Jan;265(1):24-31. doi: 10.1007/s00415-017-8625-6. Epub 2017 Oct 12. Erratum in: J Neurol. 2017 Nov 24;:.

PMID:
29027004
45.

Prevalence of Hepatitis B and C virus infection among alcoholic individuals: importance of screening and vaccination.

Cortes VF, Taveira A, Cruz HM, Reis AA, Cezar JS, Silva BS, D'Assunção CF, Lampe E, Villar LM.

Rev Inst Med Trop Sao Paulo. 2017;59:e47. doi: 10.1590/S1678-9946201759047. Epub 2017 Aug 3.

46.

Performance of rapid diagnostic tests for detection of Hepatitis B and C markers in HIV infected patients.

Barbosa JR, Colares JKB, Flores GL, Cortes VF, Miguel JC, Portilho MM, Marques VA, Potsch DV, Brandão-Mello CE, Amendola-Pires M, Pilotto JH, Lima DM, Lampe E, Villar LM.

J Virol Methods. 2017 Oct;248:244-249. doi: 10.1016/j.jviromet.2017.08.001. Epub 2017 Aug 4.

PMID:
28782578
47.

Lack of Association between Hepatitis C Virus core Gene Variation 70/91aa and Insulin Resistance.

Scalioni LP, da Silva AP, Miguel JC, Espírito Santo MPD, Marques VA, Brandão-Mello CE, Villela-Nogueira CA, Lewis-Ximenez LL, Lampe E, Villar LM.

Int J Mol Sci. 2017 Jul 21;18(7). pii: E1444. doi: 10.3390/ijms18071444.

48.

Optimal response to dimethyl fumarate associates in MS with a shift from an inflammatory to a tolerogenic blood cell profile.

Medina S, Villarrubia N, Sainz de la Maza S, Lifante J, Costa-Frossard L, Roldán E, Picón C, Álvarez-Cermeño JC, Villar LM.

Mult Scler. 2018 Sep;24(10):1317-1327. doi: 10.1177/1352458517717088. Epub 2017 Jun 27.

PMID:
28653862
49.

Detection and molecular characterisation of a diagnosis escape variant associated with occult hepatitis B virus in Brazil.

Almeida RW, Mello FCDA, Menegoy IV, Santo MPDE, Ginuíno CF, Sousa PSF, Villar LM, Lampe E, Lewis-Ximenez LL.

Mem Inst Oswaldo Cruz. 2017 Jul;112(7):485-491. doi: 10.1590/0074-02760160477.

50.

Involved/uninvolved heavy/light chain index can predict progression in transplanted multiple myeloma patients.

Espiño M, Arteche-López A, Medina S, Muñoz-Calleja C, Blanchard MJ, Alegre A, López-Jiménez FJ, Villar LM.

Bone Marrow Transplant. 2017 Aug;52(8):1206-1207. doi: 10.1038/bmt.2017.97. Epub 2017 Jun 5. No abstract available.

Supplemental Content

Loading ...
Support Center